Quick Takeaways
- Avidity Partners Management LP filed SCHEDULE 13D/A for Dianthus Therapeutics, Inc. Common Stock, $0.001 par value (DNTH).
- Disclosed ownership: 4.9%.
- Date of event: 17 Nov 2025.
Quoteable Key Fact
"Avidity Partners Management LP disclosed 4.9% ownership in Dianthus Therapeutics, Inc. Common Stock, $0.001 par value (DNTH) on 17 Nov 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP | 4.9% | 2,104,184 | 0 | 2,104,184 | By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | 0001791827 |
| Avidity Partners Management (GP) LLC | 4.9% | 2,104,184 | 0 | 2,104,184 | By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Avidity Capital Partners Fund (GP) LP | 4.9% | 2,104,184 | 0 | 2,104,184 | By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Avidity Capital Partners (GP) LLC | 4.9% | 2,104,184 | 0 | 2,104,184 | By: /s/ Michael Gregory | Michael Gregory, Managing Member | |
| Avidity Private Master Fund I LP | 4.4% | 1,899,593 | 0 | 1,899,593 | By: Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Michael Gregory | 4.9% | 2,104,184 | 0 | 2,104,184 | By: /s/ Michael Gregory | Michael Gregory |